| Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ... Gastroenterology 156 (3), 635-646. e9, 2019 | 201 | 2019 |
| Real-world effectiveness from the Asia pacific rim liver consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients treated … HI Yang, ML Yeh, GL Wong, CY Peng, CH Chen, HN Trinh, KS Cheung, ... The Journal of infectious diseases 221 (3), 389-399, 2020 | 75 | 2020 |
| Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study MH Nguyen, HI Yang, A Le, L Henry, N Nguyen, MH Lee, J Zhang, ... The Journal of infectious diseases 219 (1), 10-18, 2018 | 75 | 2018 |
| Cure with interferon‐free direct‐acting antiviral is associated with increased survival in patients with hepatitis C virus‐related hepatocellular carcinoma from both east and west H Dang, YH Yeo, S Yasuda, CF Huang, E Iio, C Landis, DW Jun, ... Hepatology 71 (6), 1910-1922, 2020 | 68 | 2020 |
| Reduction of chronic hepatitis B‐related hepatocellular carcinoma with anti‐viral therapy, including low risk patients D Lin, HI Yang, N Nguyen, J Hoang, Y Kim, V Vu, A Le, K Chaung, ... Alimentary pharmacology & therapeutics 44 (8), 846-855, 2016 | 61 | 2016 |
| Differential serum cytokine profiles in patients with chronic hepatitis b, c, and hepatocellular carcinoma J Estevez, VL Chen, O Podlaha, B Li, A Le, P Vutien, ET Chang, ... Scientific reports 7 (1), 11867, 2017 | 55 | 2017 |
| Increasing co-morbidities in chronic hepatitis B patients: Experience in primary care and referral practices during 2000–2015 A Liu, A Le, J Zhang, C Wong, C Wong, L Henry, MH Nguyen Clinical and translational gastroenterology 9 (3), 2018 | 49 | 2018 |
| Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis JK Hoang, HI Yang, A Le, NH Nguyen, D Lin, VD Vu, K Chaung, ... Medicine 95 (31), 2016 | 47 | 2016 |
| Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease CY Chang, P Nguyen, A Le, C Zhao, A Ahmed, T Daugherty, G Garcia, ... Medicine 96 (6), 2017 | 45 | 2017 |
| Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study MR Ladenheim, NG Kim, P Nguyen, A Le, ML Stefanick, G Garcia, ... BMJ open gastroenterology 3 (1), e000107, 2016 | 43 | 2016 |
| Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis SA Tran, A Le, C Zhao, J Hoang, LA Yasukawa, S Weber, L Henry, ... BMJ open gastroenterology 5 (1), e000192, 2018 | 36 | 2018 |
| Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B C Wang, V Chen, V Vu, A Le, L Nguyen, C Zhao, CR Wong, N Nguyen, ... Medicine 95 (35), 2016 | 36 | 2016 |
| Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors A Wong, A Le, MH Lee, YJ Lin, P Nguyen, S Trinh, H Dang, MH Nguyen Scientific reports 8 (1), 7164, 2018 | 24 | 2018 |
| Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience P Nguyen, P Vutien, J Hoang, S Trinh, A Le, LA Yasukawa, S Weber, ... BMJ open gastroenterology 4 (1), e000181, 2017 | 24 | 2017 |
| Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B–related Hepatocellular Carcinoma VL Chen, AK Le, NG Kim, LH Kim, NH Nguyen, PP Nguyen, C Zhao, ... Clinical Gastroenterology and Hepatology 14 (6), 887-895. e1, 2016 | 24 | 2016 |
| Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia YA Kim, J Estevez, A Le, D Israelski, O Baatarkhuu, T Sarantuya, ... BMJ open gastroenterology 3 (1), e000119, 2016 | 15 | 2016 |
| Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response AK Le, C Zhao, JK Hoang, SA Tran, CY Chang, M Jin, NH Nguyen, ... Alimentary pharmacology & therapeutics 46 (6), 605-616, 2017 | 13 | 2017 |
| Racial/ethnic-and county-specific prevalence of chronic hepatitis B and its burden in California M Toy, B Wei, TS Virdi, A Le, H Trinh, J Li, J Zhang, AW Hsing, SK So, ... Hepatology, medicine and policy 3 (1), 6, 2018 | 11 | 2018 |
| Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis X Gao, HI Yang, H Trinh, D Jeong, J Li, J Zhang, A Le, J Hoang, P Nguyen, ... European journal of gastroenterology & hepatology 32 (9), 1207-1211, 2020 | 7 | 2020 |
| Reduced incidence of hepatocellular carcinoma with tenofovir in chronic hepatitis B patients with and without cirrhosis—a propensity score matched study MH Nguyen, HI Yang, A Le, L Henry, N Nguyen, MH Lee, J Zhang, ... J Infect Dis 219 (1), 10-8, 2018 | 6 | 2018 |
